NAD+ IV Therapy and Supplements: Does It Actually Slow Aging? What the Human Evidence Shows

⚡ The Short Answer

• Does NAD+ matter for aging biology? Yes. It is central to how cells make energy and repair DNA, and levels are reported to fall with age.
• Do supplements raise NAD+ levels in people? Yes. Multiple human trials show NMN and NR increase blood NAD+ or related metabolites.
• Is there proof they slow human aging? No. Trials so far are small and short, results on health outcomes are mixed, and none has measured lifespan or the onset of age-related disease.
• What about IV NAD+? Human data are very limited. The few small studies suggest short-term tolerability, but infusions of NAD+ itself often cause unpleasant side effects, and long-term safety is unknown.

🧬 What NAD+ Is and Why Everyone Is Talking About It

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell. Think of it as a shuttle that carries electrons during the reactions that turn food into usable energy. It also serves as fuel for enzymes involved in DNA repair, cellular metabolism and immune function.

Interest in NAD+ for aging comes from two lines of research:

1. Levels appear to drop with age. Reports describe lower NAD+ in various tissues of older people and animals, which researchers suspect may contribute to age-related decline.
2. Animal studies are encouraging. In mice and other animals, raising NAD+ with precursors such as NMN or NR has improved markers of health and, in some experiments, extended healthspan.

Human biology is more complicated. Mouse results often fail to carry over to people, and a lower NAD+ level in an older person does not prove that low NAD+ is causing their aging rather than being a consequence of it. That distinction is the whole debate.

The “precursor” idea. Your cells do not usually absorb intact NAD+ efficiently. Instead, they build it from smaller pieces. Two of the best-known building blocks are NMN (nicotinamide mononucleotide), which the body converts to NAD+ in a short chain of steps, and NR (nicotinamide riboside), a form of vitamin B3 that cells convert to NMN and then to NAD+. Most oral supplements on the market are one of these two.

💊 NAD+ Supplements: What Human Trials Actually Show

This is the part of the evidence base that is most solid, so it is worth going through carefully.

They do raise NAD+ levels. The most consistent finding across trials is that these supplements do what they claim biochemically. A 2018 randomized, placebo-controlled crossover trial of NR in healthy middle-aged and older adults, run over two six-week periods, found it was well tolerated and effectively stimulated NAD+ metabolism. A placebo-controlled trial of 30 healthy people found that oral NMN was safe over the study period and efficiently raised blood NAD+ levels. A trial in 42 older men gave 250 mg of NMN daily for 6 or 12 weeks; it was well tolerated and caused no significant deleterious effect, and it raised blood NAD+.

Put side by side, these studies tell a consistent story: results depend on who is studied (prediabetic women versus healthy older men versus obese men), which precursor is used, and what outcome is measured. A benefit in one group does not automatically apply to another.

Why the evidence is still thin. Even the positive trials share limitations that matter when someone sells a capsule as an “anti-aging” product: small samples (often a few dozen people), short duration (weeks to a few months, while aging happens over decades), surrogate outcomes (blood NAD+ levels, grip strength and insulin clamp measures are stand-ins, not the same as living longer or avoiding disease), narrow populations, and in some cases industry involvement in trials testing branded products. In short, no human trial has shown that NMN or NR slows biological aging, extends lifespan or delays the onset of age-related disease.

Safety of oral precursors. The good news is that short-term safety looks reassuring. Across the trials above, NMN and NR were generally well tolerated over weeks to a few months. Dr. Rachele Pojednic, who studies NAD+ therapies, told NPR that studies are showing remarkable safety. That reassurance has limits: “well tolerated for 12 weeks in selected volunteers” is not the same as “safe for decades in everyone,” particularly for people with existing medical conditions or those who take other medications. Long-term data simply do not exist yet.

💉 NAD+ IV Therapy: The Evidence Is Much Thinner

If oral supplements have a modest, mixed evidence base, IV NAD+ has a much smaller one. Clinics deliver NAD+ (or, increasingly, NR) directly into a vein over a period that can range from under an hour to several hours depending on the dose and the clinic’s protocol. The marketing logic is that going around the digestive system should deliver more of the molecule more quickly.

The side effect problem. Reported side effects of NAD+ infusions include nausea, malaise, sweating, stomach cramping and headache. Researchers have raised a possible explanation: when NAD+ sits outside cells, it can act as a danger signal that alerts the immune system and may have pro-inflammatory effects. That could be one reason the intact molecule is harder to tolerate than precursors. Practical consequence: clinics often slow the infusion rate to reduce symptoms, which is why a “drip” can take hours.

A note on company-sourced claims. You may come across a 2024 press release from ChromaDex, the maker of a patented NR product, describing an IV NR product as having superior tolerability and a 75 percent shorter infusion time than NAD+ IV. Treat this as what it is: a company announcement referring to a preprint, from a business that sells the alternative. It is a useful signal, not independent proof. The same release acknowledges that oral and intravenous NAD+ supplementation is virtually untested in humans, so its risks, safety and efficacy are unknown.

What nobody knows yet: whether IV delivery produces better health outcomes than oral precursors (no trial has shown this), whether repeated infusions over months or years are safe, how benefits (if any) compare against the cost, and whether IV NAD+ changes any real marker of biological aging.

📊 IV vs. Oral: A Side-by-Side Comparison

📋 How Regulators See These Products

NMN and the FDA. NMN’s legal status has changed over the past few years, and many articles online are out of date. In 2022, the FDA took the position that NMN could not be sold as a dietary supplement because it had been authorized for investigation as a drug first. On September 29, 2025, the FDA reversed course in responding to citizen petitions. It concluded NMN is not excluded from the definition of a dietary supplement, because evidence showed it was marketed as a supplement in the U.S. before it was authorized for drug investigation, citing marketing as early as 2017. In December 2025 the agency sent letters to companies that had filed New Dietary Ingredient notifications confirming this status.

What this means for you: NMN is lawful to sell as a supplement. It does not mean the FDA has said it works, that it slows aging, or that every product is high quality. NMN remains a New Dietary Ingredient, so each company must satisfy premarket notification requirements, and products without proper notifications can still face enforcement.

Supplements are not drugs. Dietary supplements in the U.S. are not approved by the FDA for effectiveness before sale. No NAD+ product that we found has been approved by the FDA to treat or slow aging. Any clinic or brand that suggests otherwise is going beyond the evidence. IV products given in wellness clinics are typically compounded rather than approved drugs, and quality depends heavily on the pharmacy and the clinic — another reason to ask detailed questions before booking.

⚠️ Safety: Who Should Be Careful

Because most trials enroll healthy volunteers, people with medical conditions are underrepresented. Talk with a doctor first if any of the following apply: you are pregnant, trying to conceive or breastfeeding; you have a current or past cancer diagnosis, or are being treated for any serious illness; you take prescription medications, particularly for diabetes, blood pressure or liver conditions; you have kidney or liver disease; or you have a history of reactions to IV treatments.

💰 The Cost Question

NPR’s reporting put it plainly: the real question is whether the evidence supports spending hundreds or even thousands of dollars on this molecule. Oral supplements are cheaper but are a recurring expense. IV sessions are typically sold in packages, which raises the total. A useful way to think about it: if the benefit is unproven, the price is paying for hope rather than results; if you spend on a drip, there is no head-to-head evidence that it outperforms a supplement taken by mouth; and insurance does not typically cover wellness infusions for anti-aging.

🚩 Red Flags in NAD+ Marketing

• “Reverses aging” or “turns back the clock.” No human trial supports this.
• “Clinically proven” with no study named, or a study done on mice.
• Dramatic testimonials from celebrities or influencers rather than trial data.
• Pressure to buy a package immediately or a discount that expires today.
• No mention of side effects or a claim that it is free of risk.
• Claims to treat addiction, depression, long COVID or chronic fatigue without medical oversight.
• Cherry-picked numbers, such as a rise in blood NAD+ presented as proof of a health benefit.

🏃 What Has Better Evidence for Healthy Aging

Researchers who study aging tend to point to unglamorous things first: regular physical activity, combining aerobic and strength training (some commentators note that NAD+ boosters do not appear to be better than exercise at raising NAD+ itself); sleep of consistent length and quality; a varied diet rich in vegetables, fruit, legumes and whole grains; not smoking and keeping alcohol moderate or low; staying socially connected and managing stress; and routine medical care, including blood pressure, blood sugar and cholesterol checks, and recommended screenings. None of these is exciting to market. All of them have far larger bodies of evidence than any NAD+ product.

✅ Questions to Ask Before Booking an IV

• Who is the licensed clinician supervising the infusion, and are they present?
• Where is the product compounded, and is it from a licensed pharmacy?
• What dose and infusion time will be used, and why?
• What side effects should I expect, and what will you do about them?
• What evidence supports this specific protocol for my goal? If the answers are vague, that is information.

🎯 A Reasonable Way to Think About NAD+

If you are curious about NAD+: treat it as an experiment, not a treatment — the honest framing is that you are trying something with unproven benefits. Start with the basics; if sleep, exercise and diet are not in order, no supplement will compensate. If you try an oral precursor, choose a product with third-party testing, stick to doses used in trials, and discuss it with your doctor, especially if you take medication. Be most skeptical of IV therapy, since the evidence is thinnest, costs are highest, and side effects with NAD+ itself are common. Track something real — rather than relying on how you feel, ask your doctor which measurable markers matter for you. And revisit this topic in a few years, since larger, longer trials are underway across the field, and the picture may change.

❓ Frequently Asked Questions

📚 Sources & References

• “Chronic nicotinamide riboside supplementation is well tolerated and elevates NAD+ in healthy middle-aged and older adults” (Martens et al., 2018)
• “Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood NAD+ Levels in Healthy Subjects,” Frontiers in Nutrition, 2022
• “Chronic NMN supplementation elevates blood NAD+ levels and alters muscle function in healthy older men,” npj Aging, 2022
• Lifespan.io, “Human Clinical Trials of NMN for Safety and Effectiveness”
• “Effects of NMN Supplementation on Muscle and Liver Functions Among the Middle-aged and Elderly: Systematic Review and Meta-analysis,” Current Pharmaceutical Biotechnology
• Dollerup et al., 2019, “Nicotinamide riboside does not alter mitochondrial respiration, content or morphology in skeletal muscle from obese and insulin resistant men,” J Physiol
• “Comparison of commercially administered NAD+ IV and NR IV,” Frontiers in Aging, 2026
• NPR, “Marketers say NAD+ pills and infusions can boost longevity. What’s the evidence?”, May 2026
• ChromaDex press release on Niagen+ IV (company-sourced), Business Wire, 2024
• Nutritional Outlook, “FDA responds to citizen petitions on NMN,” September 2025
• Venable, “FDA Declares Nicotinamide Mononucleotide Is a Dietary Supplement”
• Nutraceuticals World, “FDA confirms status of NMN as a supplement ingredient,” December 2025

💡 The Bottom Line

NAD+ is a legitimate and fascinating area of aging research. Oral precursors like NMN and NR reliably raise NAD+ levels in people and look reasonably safe in the short term. Some trials in specific groups hint at benefits for muscle function and insulin sensitivity, while others find nothing. IV therapy rests on an even thinner foundation of very small studies, with frequent side effects when NAD+ itself is infused. What no one can yet say is that any of these approaches slows human aging. The honest summary is “promising biology, unproven medicine.” Until larger and longer trials report back, the best-supported anti-aging strategies remain movement, sleep, good food and regular check-ups. If you decide to try NAD+, go in with realistic expectations, medical guidance and a firm budget.